CORRECTION article

Front. Pharmacol., 10 June 2025

Sec. Experimental Pharmacology and Drug Discovery

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1611105

Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model

  • 1. Department of Emergency Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • 2. Institute of Anatomy and Cell Biology, Medical College, Zhejiang University, Hangzhou, China

  • 3. Institute of Human Anatomy, Histology and Embryology, Basic Medical College, Zhejiang Chinese Medical University, Hangzhou, China

  • 4. Department of Rehabilitation in Traditional Chinese Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

  • 5. Department of Pulmonology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China

Article metrics

View details

887

Views

242

Downloads

In the published article, there was an error in Supplementary Figure S7 as published. The magnification of Supplementary Figure S7S is different from others. This has been corrected.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

C16, EAE, Tie2, integrin, PI3K/Akt pathways

Citation

Zhou W, Qu H, Fu X-X, Xu M-M, Li Q, Jiang Y and Han S (2025) Corrigendum: Neuroprotective effects of a novel peptide through the Rho-integrin-Tie2 and PI3K/Akt pathways in experimental autoimmune encephalomyelitis model. Front. Pharmacol. 16:1611105. doi: 10.3389/fphar.2025.1611105

Received

13 April 2025

Accepted

29 May 2025

Published

10 June 2025

Volume

16 - 2025

Edited and reviewed by

C. James Chou, Medical University of South Carolina, United States

Updates

Copyright

*Correspondence: Yuan Jiang, ; Qiang Li, , ; Shu Han,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics